Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > NorthWest Biotherapeutics (NWBO)

London DCVax and Compassionate Use finally some good

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
john1045 Member Profile
 
Followed By 23
Posts 1,612
Boards Moderated 0
Alias Born 06/09/11
160x600 placeholder
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 11/26/2014 4:08:42 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/19/2014 3:26:04 PM
NW BIO ANNOUNCES FINANCINGS TOTALING $35 MILLION TO EXPAND AND ACCELERATE DCVAX®-L AND DCVAX®-DIRECT PROGRAMS "PR Newswire (US)" - 11/19/2014 3:20:00 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 11/14/2014 4:02:19 PM
Four Companies to Keep on Your Radar & Special Report on Emerging Beverage Contender by Small Cap IR "InvestorsHub NewsWire" - 11/10/2014 7:00:00 AM
NW BIO MAKING A JOINT POSTER PRESENTATION ON ITS DCVAX-DIRECT TRIAL AT THE 29TH ANNUAL SITC MEETING "PR Newswire (US)" - 11/7/2014 9:15:00 AM
Hot Stocks to Follow for Investment Opportunity & Special Profile "InvestorsHub NewsWire" - 11/6/2014 6:00:00 AM
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securi... "PR Newswire (US)" - 10/28/2014 2:41:00 PM
DCVAX®-L HOSPITAL EXEMPTION PROGRAM NOW UNDER WAY IN GERMANY "PR Newswire (US)" - 10/14/2014 9:01:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/10/2014 4:31:35 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/8/2014 4:11:25 PM
NW BIO ANNOUNCES $11.5 MILLION FINANCING "PR Newswire (US)" - 10/7/2014 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/18/2014 9:24:39 AM
NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) "PR Newswire (US)" - 9/16/2014 8:00:00 AM
NW BIO CEO TO PRESENT AT SMi's 3rd ANNUAL CANCER VACCINES CONFERENCE IN LONDON "PR Newswire (US)" - 9/15/2014 8:00:00 AM
NW BIO TO PRESENT UPDATES AT RODMAN RENSHAW 16TH ANNUAL GLOBAL INVESTMENT CONFERENCE "PR Newswire (US)" - 9/8/2014 8:15:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/25/2014 4:26:15 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/19/2014 5:29:40 PM
NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING "PR Newswire (US)" - 8/19/2014 2:44:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/15/2014 6:02:42 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/14/2014 4:17:12 PM
NW BIO ANNOUNCES PRICING OF $17.5 MILLION OFFERING OF CONVERTIBLE NOTES "PR Newswire (US)" - 8/14/2014 11:47:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/11/2014 5:17:29 PM
NW BIO OBTAINS APPROVALS FOR ENHANCEMENTS OF PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER "PR Newswire (US)" - 8/11/2014 8:15:00 AM
john1045   Thursday, 04/12/12 08:01:24 AM
Re: None
Post # of 25184 
London DCVax and Compassionate Use finally some good news and the 10Q is due so I am sure we will learn more when that comes out in next couple of days.

http://nwbio.com/pdf/press2012.04.12.pdf

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist